Re: Tom JH Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52

被引：2

作者：

Poletajew, Slawomir ^{[1
]}

Radziszewski, Piotr ^{[1
]}

Palou, Juan ^{[2
]}

机构：

[1] Med Univ Warsaw, Dept Urol, 4 Lindleya St, PL-02005 Warsaw, Poland

[2] Univ Autonoma Barcelona, Dept Urol, Fdn Puigvert, Barcelona, Spain

来源：

EUROPEAN UROLOGY | 2017年 / 71卷 / 01期

关键词：

D O I：

10.1016/j.eururo.2016.06.042

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E29 / E30

页数：2

共 25 条

[1] Re: Tom JH Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52
Garg, Harshit
Nayak, Brusabhanu
Singh, Prabhjot
EUROPEAN UROLOGY, 2019, 75 (02) : E25 - E25
[2] Reply to Harshit Garg, Brusabhanu Nayak and Prabhjot Singh's Letter to the Editor Re: Tom JH Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52
Arends, Tom J. H.
Witjes, J. Alfred
EUROPEAN UROLOGY, 2019, 75 (02) : E26 - E26
[3] Reply to Slawomir Poletajew, Piotr Radziszewski, Juan Palou's Letter to the Editor re: Tom JH Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohy-perthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52
Arends, Tom J. H.
Witjes, J. Alfred
EUROPEAN UROLOGY, 2017, 71 (01) : E31 - E32
[4] Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer
Arends, Tom J. H.
Nativ, Ofer
Maffezzini, Massimo
de Cobelli, Ottavio
Canepa, Giorgio
Verweij, Fabrizio
Moskovitz, Boaz
van der Heijden, Antoine G.
Witjes, J. Alfred
EUROPEAN UROLOGY, 2016, 69 (06) : 1046 - 1052
[5] Re: Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C versus bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer Editorial Comment
Chang, Sam S.
JOURNAL OF UROLOGY, 2018, 200 (04) : 696 - 697
[6] Re: Contemporary Cost-Effectiveness Analysis Comparing Sequential bacillus Calmette-Guerin and Electromotive Mitomycin versus bacillus Calmette-Guerin Alone for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer Editorial Comment
Chang, Sam S.
JOURNAL OF UROLOGY, 2015, 194 (03) : 666 - 666
[7] Rebuttal from Authors re: Richard J. Sylvester. Bacillus Calmette-Guerin versus Mitomycin C for the Treatment of Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: The Debate Continues. Eur Urol 2009;56:266-8
Jarvinen, Riikka
Kaasinen, Eero
Sankila, Anna
Rintala, Erkki
EUROPEAN UROLOGY, 2009, 56 (02) : 268 - 269
[8] Re: Per-Uno Malmstrom, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247-56
Aldemir, Mustafa
Canda, Abdullah Erdem
Balbay, Mevlana Derya
EUROPEAN UROLOGY, 2010, 58 (02) : E23 - E23
[9] Re: Per-Uno Malmstrom, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247-56
Lamm, Donald
Boehle, Andreas
Palou, Joan
Persad, Raj
Brausi, Maurizio
Colombel, Marc
Akaza, Hideyuki
Buckley, Roger
EUROPEAN UROLOGY, 2010, 57 (02) : E7 - E9
[10] Re: Wei Shen Tan, Aaron Prendergast, Charlotte Ackermann, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press.
Campodonico, Fabio
Mattioli, Francesca
Introini, Carlo
EUROPEAN UROLOGY, 2023, 83 (02) : E56 - E57

← 1 2 3 →